- Report
- March 2024
- 181 Pages
Global
From €3262EUR$3,374USD£2,804GBP
€3624EUR$3,749USD£3,115GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- April 2024
- 189 Pages
Global
From €4785EUR$4,950USD£4,113GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1933EUR$2,000USD£1,662GBP
- Report
- October 2023
- 181 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,448GBP
- Report
- October 2023
- 151 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- January 2024
- 163 Pages
Global
€4829EUR$4,995USD£4,150GBP
- Report
- January 2024
- 150 Pages
Global
From €4689EUR$4,850USD£4,030GBP
- Report
- March 2024
- 143 Pages
Global
From €3769EUR$3,899USD£3,240GBP
- Report
- February 2024
- 120 Pages
Global
From €4592EUR$4,750USD£3,947GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1933EUR$2,000USD£1,662GBP
- Report
- February 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- November 2023
- 182 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 145 Pages
Global
From €3045EUR$3,150USD£2,617GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4785EUR$4,950USD£4,113GBP
- Report
- May 2021
- 177 Pages
United States
€1445EUR$1,495USD£1,242GBP
- Report
- February 2023
- 152 Pages
Global
From €5317EUR$5,500USD£4,570GBP
- Report
- January 2022
- 200 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,282GBP
The Insomnia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Insomnia drugs are used to treat difficulty sleeping, and can be divided into two categories: sedative-hypnotics and non-sedative hypnotics. Sedative-hypnotics are drugs that act on the central nervous system to induce sleep, while non-sedative hypnotics are drugs that act on the brain to improve sleep quality without causing sedation. Commonly prescribed insomnia drugs include benzodiazepines, non-benzodiazepines, and melatonin receptor agonists.
Some companies in the Insomnia Drug market include Sanofi, Pfizer, Merck, GlaxoSmithKline, and Takeda. Show Less Read more